on 27 Mar 2018
Last Applicant/ Owned by
Shanghai Pharmaceutical Building
Shanghai
CN
200020
Serial Number
86249638 filed on 11th Apr 2014
Registration Number
5433650 registered on 27th Mar 2018
Correspondent Address
B. Brett Heavner
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
The color(s) blue and white is/are claimed as a feature of the mark. SHANGHAI PHARMACEUTICALS HOLDING PHARMACEUTICAL PREPARATIONS AND TRADITIONAL CHINESE MEDICINES USED AS PHARMACEUTICAL PREPARATIONS FOR THE PREVENTION AND TREATMENT OF DISEASES AND DISORDERS OF THE CARDIOVASCULAR SYSTEM, IMMUNE SYSTEM, METABOLIC SYSTEM AND GASTRO-INTESTINAL SYSTEM; PHARMACEUTICAL PREPARATIONS FOR THE PREVENTION Read More
PHARMACEUTICAL PREPARATIONS AND TRADITIONAL CHINESE MEDICINES USED AS PHARMACEUTICAL PREPARATIONS FOR THE PREVENTION AND TREATMENT OF DISEASES AND DISORDERS OF THE CARDIOVASCULAR SYSTEM, IMMUNE SYSTEM, METABOLIC SYSTEM AND GASTRO-INTESTINAL SYSTEM; PHARMACEUTICAL PREPARATIONS FOR THE PREVENTION AND TREATMENT OF NEUROPSYCHIATRIC DISEASES AND DISORDERS, VIRAL AND INFECTIOUS DISEASES, AND CANCER; PHARMACEUTICALS AND TRADITIONAL CHINESE MEDICINES USED AS PHARMACEUTICALS, NAMELY, ANTI-INFECTIVES AND ANTINEOPLASTICS
29th Dec 2017
29th Dec 2017
No 86249638
No Service/Collective Mark
No 12640.0003-0
No
No
No
No
No
No
No
No
26.09.21 -
Squares that are completely or partially shaded
The mark consists of the letters "SPH" in stylized white font inside a blue box.
| Status Date | Action Taken |
|---|---|
| 19th Oct 2023 | TEAS SECTION 8 RECEIVED |
| 27th Mar 2023 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| 27th Mar 2018 | REGISTERED-PRINCIPAL REGISTER |
| 17th Feb 2018 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 16th Feb 2018 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 29th Jan 2018 | STATEMENT OF USE PROCESSING COMPLETE |
| 23rd Jan 2018 | TEAS STATEMENT OF USE RECEIVED |
| 23rd Jan 2018 | USE AMENDMENT FILED |
| 17th Nov 2017 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 16th Nov 2017 | SOU EXTENSION 5 GRANTED |
